According to a recently-filed 13G, Glenn J. Krevlin’s Glenhill Advisors holds a 10.04 million-share position in Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX), which accounts for 5.3% of the company’s outstanding shares. Therefore, the hedge fund increased its stake in the company by 2.67 million shares since June 30.
Glenhill Advisors is a long/short equity hedge fund co-founded by Glenn J. Krevlin and Michael A. Pollack in January 2001. The New York-based investment firm uses a bottom-up stock picking approach and primarily invests in small-cap equities in public equity markets around the world. Glenhill is also widely-known for taking activist stances on its large bets, which is not the case with Allscripts Healthcare Solutions as of yet. As stated by its most recent 13F filing with the SEC, Glenhill Advisors manages a public equity portfolio with a market value of $1.42 billion.
Follow Glenn J. Krevlin's Glenhill Advisors
We follow hedge funds like Glenhill Advisors because our research has shown that their stock picks historically managed to generate alpha even though the filings are up to 45-days delayed. We used a 60-day delay in our back tests to be on the safe side and our research showed that the 15 most popular small-cap stocks among hedge funds outperformed the S&P 500 Total Return Index by an average of 95 basis points per month between 1999 and 2012. After adjusting for risk, our calculations revealed that these stocks’ monthly alpha was 80 basis points. We have also been sharing and tracking the performance of these stocks since the end of August 2012, during which time they have returned 118%, outperforming the S&P 500 ETF by over 60 percentage points (see more details here).
Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) is a technology company that delivers information technology and services to assist healthcare organizations in achieving better clinical, financial, and operational results. To be more detailed, the company offers clinical, financial, electronic health records (EHR), connectivity, analytics, patient management, and population health products and services in the United States and Canada. The company has delivered a convincing performance thus far in 2015, with its stock gaining nearly 8% year-to-date. Clifton S. Robbins’ Blue Harbour Group and Iridian Asset Management, founded by David Cohen and Harold Levy, are the largest equity holders of Allscripts Healthcare Solutions within our database, owning 14.42 million shares and 10.95 million shares, respectively.
Let’s now discuss some factors that might have assisted the company in delivering its solid performance this year. The electronic health/medical record (EHR/EMR) solutions developed by Allscripts Healthcare Solutions surely played an important role in the company’s growth and development. The U.S healthcare IT industry is currently going through a rapid evolution, which was mainly triggered by new laws and regulations. The healthcare sector is quickly moving towards an environment where EHRs are becoming an industry standard. The Health Information Technology for Economic and Clinical Health Act of 2009 has also served and continues to serve as an important driver of healthcare IT adoption, which allows Allscripts Healthcare Solutions to grow and expand its client base at a very high pace. The company is well-positioned to make the most of these industry changes. Just recently, research company Black Book awarded top scores for Allscripts’ ambulatory EHRs, which will most likely assist the company in increasing the visibility of its solutions. Black Book’s Chief Executive Officer, Doug Brown, asserted that the ambulatory practices that use Allscripts’ solutions indicate a high level of satisfaction, which clearly suggests that the company has all the cards to take advantage of its strong position in the industry.
Allscripts Healthcare Solutions Inc. (NASDAQ:MDRX) recently posted its financial results for the second quarter, posting total revenue of $352 million, compared to $351 million reported a year ago. It’s worth mentioning that the higher revenue from subscription-based software sales and managed services was mainly offset by lower revenues from implementation and consulting services. In turn, this indicates that the company has been able to achieve a higher market penetration with its software solutions. At the same time, Allscripts’ net loss for the quarter narrowed quite significantly to $3.22 million, compared to a loss of $17.77 million reported in the same quarter a year ago.
Disclosure: None
